0001140361-21-010348.txt : 20210326
0001140361-21-010348.hdr.sgml : 20210326
20210326181744
ACCESSION NUMBER: 0001140361-21-010348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210324
FILED AS OF DATE: 20210326
DATE AS OF CHANGE: 20210326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Kinnari
CENTRAL INDEX KEY: 0001725929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 21778927
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
form4.xml
FORM 4
X0306
4
2021-03-24
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001725929
Patel Kinnari
C/O ROCKET PHARMACEUTICALS, INC.
9 CEDARBROOK DRIVE
CRANBURY
NJ
08512
true
Chief Operating Officer
Common Stock
2021-03-24
4
M
0
55869
1.21
A
150846
D
Common Stock
2021-03-24
4
M
0
38093
1.69
A
188939
D
Common Stock
6675
I
By Spouse
Common Stock
94937
I
By Adaptive Technology LLC
Stock Option (Right to Buy)
1.21
2021-03-24
4
M
0
55869
0
D
2026-04-18
Common Sock
55869
0
D
Stock Option (Right to Buy)
1.69
2021-03-24
4
M
0
38093
0
D
2027-04-12
Common Sock
38093
0
D
The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.
This option is fully vested and exercisable.
/s/ Sara Turken, as attorney-in-fact for Kinnari Patel
2021-03-26